Facebook
Twitter
LinkedIn
Forward
Pulmonary hypertension, frequently complicating the course of patients with fibrotic interstitial lung disease, is associated with significantly increased morbidity and mortality.
|
Hypoxemic respiratory failure is one of the leading causes of mortality in intensive care.
|
Lung health, the development of lung disease, and how well a person with lung disease is able to live all depend on a wide range of societal factors.
|
In study after study, marijuana use has been found to be associated with increased forced vital capacity (FVC).
|
Chronic obstructive pulmonary disease (COPD) is a major public health problem in the Americas (a region of the world comprising North, Central, and South America), although there is substantial var
|
The definition of pulmonary hypertension (PH) has been revised recently, with the mean pulmonary artery pressure (mPAP) threshold (assessed by right heart catheterization) reduced from ≥25mm Hg to
|
 |
Alpha-1 antitrypsin deficiency (AATD) is an underrecognized condition with only a small minority of affected individuals diagnosed, long delays between initial symptoms and diagnosis, and evidence
|
An evidence-based guideline for the treatment of patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) was created in 2023 by a panel of multidisciplinary experts.
|